BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17958518)

  • 1. Review article: a pharmacoeconomic analysis of thrombocytopenia in chronic liver disease.
    Brown RS
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():41-8. PubMed ID: 17958518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: thrombocytopenia in chronic liver disease.
    Poordad F
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():5-11. PubMed ID: 17958514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.
    Afdhal NH; McHutchison JG
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():29-39. PubMed ID: 17958517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches.
    Afdhal NH; Esteban R
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():1-4. PubMed ID: 17958513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
    Cantor SB; Elting LS; Hudson DV; Rubenstein EB
    Cancer; 2003 Jun; 97(12):3099-106. PubMed ID: 12784347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia.
    Poordad F; Theodore D; Sullivan J; Grotzinger K
    J Med Econ; 2011; 14(2):194-206. PubMed ID: 21348807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
    de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
    BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of infusion rate on platelet outcomes and patient responses in children with cancer: an in vitro and in vivo study.
    Norville R; Hinds P; Wilimas J; Fischl S; Kunkel K; Fairclough D
    Oncol Nurs Forum; 1997; 24(10):1789-93. PubMed ID: 9399276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
    Giannini EG
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1055-65. PubMed ID: 16611265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures.
    Barnett CL; Mladsi D; Vredenburg M; Aggarwal K
    J Med Econ; 2018 Aug; 21(8):827-834. PubMed ID: 29912593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
    Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
    Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
    Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very high users of platelet transfusions in the neonatal intensive care unit.
    Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
    Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia in the neonate.
    Roberts I; Stanworth S; Murray NA
    Blood Rev; 2008 Jul; 22(4):173-86. PubMed ID: 18433954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and treatment of severe and prolonged thrombocytopenia in neonates.
    Sola MC
    Clin Perinatol; 2004 Mar; 31(1):1-14. PubMed ID: 15183652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease.
    Elsaid MI; Rustgi VK; Loo N; Aggarwal K; Li-McLeod J; Niu X; Poordad F
    J Med Econ; 2020 Apr; 23(4):378-385. PubMed ID: 31777291
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.